These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18627596)

  • 1. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
    de la Roche M; Worm J; Bienz M
    BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
    Hoffmans R; Basler K
    Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEF1 and B9L shield β-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.
    de la Roche M; Ibrahim AE; Mieszczanek J; Bienz M
    Cancer Res; 2014 Mar; 74(5):1495-505. PubMed ID: 24419084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.
    Brack AS; Murphy-Seiler F; Hanifi J; Deka J; Eyckerman S; Keller C; Aguet M; Rando TA
    Dev Biol; 2009 Nov; 335(1):93-105. PubMed ID: 19699733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
    Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
    Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.
    Herbst A; Jurinovic V; Krebs S; Thieme SE; Blum H; Göke B; Kolligs FT
    BMC Genomics; 2014 Jan; 15():74. PubMed ID: 24467841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.
    van Tienen LM; Mieszczanek J; Fiedler M; Rutherford TJ; Bienz M
    Elife; 2017 Mar; 6():. PubMed ID: 28296634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
    Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
    Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
    Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
    EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
    Gay DM; Ridgway RA; Müller M; Hodder MC; Hedley A; Clark W; Leach JD; Jackstadt R; Nixon C; Huels DJ; Campbell AD; Bird TG; Sansom OJ
    Nat Commun; 2019 Feb; 10(1):723. PubMed ID: 30760720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
    Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.
    Ou CY; LaBonte MJ; Manegold PC; So AY; Ianculescu I; Gerke DS; Yamamoto KR; Ladner RD; Kahn M; Kim JH; Stallcup MR
    Mol Cancer Res; 2011 May; 9(5):660-70. PubMed ID: 21478268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.